Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000964044> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2000964044 endingPage "5148" @default.
- W2000964044 startingPage "5144" @default.
- W2000964044 abstract "The persistence of anti-hepatitis A virus antibody concentrations was followed over 3 years in 177 healthy children following primary and booster vaccination with an inactivated hepatitis A vaccine, Avaxim 80 pediatric. Seroconversion rates (post-immunization anti-HAV antibody concentration >or=20 mIU/mL) and geometric mean concentrations (GMC) were estimated for each of three age groups: 18 month--3 years, 4--8 years, and 9--15 years. Only subjects who were initially HAV-seronegative at inclusion (<20 mIU/mL) were analyzed. Follow-up visits at years 1, 2, and 3 involved 177, 149, and 135 children, respectively. A decline in GMCs of about 74% occurred during the first year, from 3,060 to 814 mIU/mL overall, but did not continue during years 2 and 3. All subjects remained seropositive (antibody concentration >or=20 mIU/mL), with overall GMCs of 814, 891, and 924 mIU/mL in years 1--3, respectively. The inactivated hepatitis A study-vaccine resulted in sustained seroprotective antibody concentrations in 100% of these children, without a significant decline in antibiotic concentrations over the 3 years following booster injection, thus demonstrating the long-term protection expected with this vaccine." @default.
- W2000964044 created "2016-06-24" @default.
- W2000964044 creator A5028308515 @default.
- W2000964044 creator A5086250528 @default.
- W2000964044 creator A5088622420 @default.
- W2000964044 date "2005-10-01" @default.
- W2000964044 modified "2023-09-26" @default.
- W2000964044 title "Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up" @default.
- W2000964044 cites W1967596859 @default.
- W2000964044 cites W1976304363 @default.
- W2000964044 cites W2038779582 @default.
- W2000964044 cites W2046558742 @default.
- W2000964044 cites W2051921105 @default.
- W2000964044 cites W2070976749 @default.
- W2000964044 cites W2072508545 @default.
- W2000964044 cites W2076717417 @default.
- W2000964044 cites W2079832922 @default.
- W2000964044 cites W2082842731 @default.
- W2000964044 cites W2085919647 @default.
- W2000964044 cites W2127041785 @default.
- W2000964044 doi "https://doi.org/10.1016/j.vaccine.2005.06.017" @default.
- W2000964044 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16043271" @default.
- W2000964044 hasPublicationYear "2005" @default.
- W2000964044 type Work @default.
- W2000964044 sameAs 2000964044 @default.
- W2000964044 citedByCount "11" @default.
- W2000964044 countsByYear W20009640442013 @default.
- W2000964044 countsByYear W20009640442014 @default.
- W2000964044 countsByYear W20009640442015 @default.
- W2000964044 countsByYear W20009640442019 @default.
- W2000964044 countsByYear W20009640442020 @default.
- W2000964044 crossrefType "journal-article" @default.
- W2000964044 hasAuthorship W2000964044A5028308515 @default.
- W2000964044 hasAuthorship W2000964044A5086250528 @default.
- W2000964044 hasAuthorship W2000964044A5088622420 @default.
- W2000964044 hasConcept C121332964 @default.
- W2000964044 hasConcept C12590561 @default.
- W2000964044 hasConcept C126322002 @default.
- W2000964044 hasConcept C1276947 @default.
- W2000964044 hasConcept C159654299 @default.
- W2000964044 hasConcept C187212893 @default.
- W2000964044 hasConcept C203014093 @default.
- W2000964044 hasConcept C203165030 @default.
- W2000964044 hasConcept C22070199 @default.
- W2000964044 hasConcept C2775876817 @default.
- W2000964044 hasConcept C2776029263 @default.
- W2000964044 hasConcept C2777451964 @default.
- W2000964044 hasConcept C2780799908 @default.
- W2000964044 hasConcept C2780801004 @default.
- W2000964044 hasConcept C2780868878 @default.
- W2000964044 hasConcept C71924100 @default.
- W2000964044 hasConceptScore W2000964044C121332964 @default.
- W2000964044 hasConceptScore W2000964044C12590561 @default.
- W2000964044 hasConceptScore W2000964044C126322002 @default.
- W2000964044 hasConceptScore W2000964044C1276947 @default.
- W2000964044 hasConceptScore W2000964044C159654299 @default.
- W2000964044 hasConceptScore W2000964044C187212893 @default.
- W2000964044 hasConceptScore W2000964044C203014093 @default.
- W2000964044 hasConceptScore W2000964044C203165030 @default.
- W2000964044 hasConceptScore W2000964044C22070199 @default.
- W2000964044 hasConceptScore W2000964044C2775876817 @default.
- W2000964044 hasConceptScore W2000964044C2776029263 @default.
- W2000964044 hasConceptScore W2000964044C2777451964 @default.
- W2000964044 hasConceptScore W2000964044C2780799908 @default.
- W2000964044 hasConceptScore W2000964044C2780801004 @default.
- W2000964044 hasConceptScore W2000964044C2780868878 @default.
- W2000964044 hasConceptScore W2000964044C71924100 @default.
- W2000964044 hasIssue "44" @default.
- W2000964044 hasLocation W20009640441 @default.
- W2000964044 hasLocation W20009640442 @default.
- W2000964044 hasOpenAccess W2000964044 @default.
- W2000964044 hasPrimaryLocation W20009640441 @default.
- W2000964044 hasRelatedWork W2000964044 @default.
- W2000964044 hasRelatedWork W2046558742 @default.
- W2000964044 hasRelatedWork W2086234981 @default.
- W2000964044 hasRelatedWork W2168105898 @default.
- W2000964044 hasRelatedWork W2347776527 @default.
- W2000964044 hasRelatedWork W2368098075 @default.
- W2000964044 hasRelatedWork W2374845807 @default.
- W2000964044 hasRelatedWork W2388122170 @default.
- W2000964044 hasRelatedWork W2419419556 @default.
- W2000964044 hasRelatedWork W2978856866 @default.
- W2000964044 hasVolume "23" @default.
- W2000964044 isParatext "false" @default.
- W2000964044 isRetracted "false" @default.
- W2000964044 magId "2000964044" @default.
- W2000964044 workType "article" @default.